R&D Systems™ Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein

Catalog No.	Quantity
2017T2050	50 μg

Catalog No. 2017T2050 Supplier R&D Systems™ Supplier No. 2017T2050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to support the adhesion of HSB2 human peripheral blood acute lymphoblastic leukemia cells. Immobilized Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera at 5 μg/mL, 100 μL/well can support 60-80% HSB2 cell adhesion, when 1 x 105 cells were added in each well of a 96-well plate.

Specifications

• Accession Number: Q8NHL6
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 10859
• Molecular Weight (g/mol): M.W. (Observed): 106 kDa, reducing conditions; M.W. (theoretical): 73.8 kDa (monomer)
• Name: ILT2/CD85j Fc Chimera
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human LILRB1/CD85j/ILT2 protein Human LILRB1/CD85j/ILT2 (Gly24-His458) (N-terminus) Accession # Q8NHL6 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: LILRB1
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in sterile PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: ILT2/CD85j/LILRB1